Lilly Logo
Trailblazer-ALZ 3

Sign Up to Get Results for the TRAILBLAZER-ALZ 3 Study

Thank you for your participation in the TRAILBLAZER-ALZ 3 Study. Your dedication to the study has been incredibly helpful for growing our understanding of Alzheimer’s disease and how to treat it. That commitment means that you should be among the first to see study results.

At this time, we don't know when results will be released.

If you register to receive notification by email and/or text, we can let you know when initial results are publicly available. When you receive your notification, it will include a link that will take you directly to the announcement of the study results.

Sign Up to Receive Study Results

How would you like to be contacted? (choose one or both)*

The TRAILBLAZER-ALZ 3

The TRAILBLAZER-ALZ 3 Study is comparing the safety and side effects of an investigational medicine for people who have normal memory and thinking, but who are at risk for developing Alzheimer's disease symptoms. 
A woman with short grey hair is hugging another woman but with long grey hair outdoors, both smiling

Let’s discover what’s possible together.

Created by CTM
© 2026 Clinical Trial Media. All Rights Reserved. The images depicted contain models and are being used for illustrative purposes only.